RG
WVE icon

Redmile Group’s Wave Life Sciences WVE Stock Holding History

Redmile Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-79,018
Closed -$443K – 91
2021
Q1 		$443K Hold
79,018
– – 0.01% 84
2020
Q4 		$622K Sell
79,018
-84,601
-52% -$710K 0.01% 85
2020
Q3 		$1.39M Sell
163,619
-251,536
-61% -$2.76M 0.03% 77
2020
Q2 		$4.32M Sell
415,155
-2,512,197
-86% -$23.6M 0.08% 74
2020
Q1 		$27.4M Sell
2,927,352
-399,141
-12% -$3.4M 0.77% 40
2019
Q4 		$26.7M Buy
3,326,493
+148,733
+5% +$3.65M 0.64% 41
2019
Q3 		$65.2M Buy
3,177,760
+458,053
+17% +$10.5M 2.18% 14
2019
Q2 		$71M Sell
2,719,707
-111,800
-4% -$3.14M 2.01% 16
2019
Q1 		$110M Buy
2,831,507
+593,900
+27% +$24.1M 3.22% 8
2018
Q4 		$94.1M Sell
2,237,607
-35,700
-2% -$1.59M 3.78% 5
2018
Q3 		$114M Buy
2,273,307
+28,800
+1% +$1.3M 3.5% 7
2018
Q2 		$85.9M Buy
2,244,507
+6,900
+0.3% +$297K 2.92% 9
2018
Q1 		$89.7M Buy
2,237,607
+28,500
+1% +$1.2M 3.46% 6
2017
Q4 		$77.5M Sell
2,209,107
-58,600
-3% -$1.71M 3.37% 5
2017
Q3 		$49.3M Buy
2,267,707
+43,300
+2% +$870K 2.43% 12
2017
Q2 		$41.4M Buy
2,224,407
+953,310
+75% +$20.5M 2.52% 11
2017
Q1 		$35M Buy
1,271,097
+319,385
+34% +$8.92M 2.27% 15
2016
Q4 		$24.9M Buy
951,712
+249,890
+36% +$8.13M 2.15% 18
2016
Q3 		$22.8M Sell
701,822
-393,651
-36% -$9.3M 1.81% 22
2016
Q2 		$22.7M Sell
1,095,473
-142,800
-12% -$2.22M 2.16% 22
2016
Q1 		$17M Buy
1,238,273
+24,646
+2% +$345K 1.74% 22
2015
Q4 		$18.3M Buy
+1,213,627
New +$19M 1.37% 27

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Redmile Group's WVE Position: Q2 2021 in Review

Redmile Group sold out of Wave Life Sciences (WVE) in Q2 2021, closing a stake of 79,018 shares — an estimated $443K sold.

Redmile Group first reported a position in WVE in Q4 2015 and held it in 22 quarters. The position peaked at $114M in Q3 2018. 87 funds tracked by Wall St. Rank hold WVE as of Q2 2021.

  • Redmile Group reported no remaining Wave Life Sciences position as of Q2 2021 after selling out during the quarter.
  • Redmile Group sold 79,018 Wave Life Sciences shares in Q2 2021, an estimated $443K.
  • Redmile Group first reported a position in Wave Life Sciences in Q4 2015 and held it in 22 quarters.
  • Redmile Group's Wave Life Sciences position peaked at $114M in Q3 2018.
  • 87 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2021.

Based on Redmile Group's 13F filing for Q2 2021, filed 16 Aug 2021.